Geneos Wealth Management’s The ExOne Company XONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,045
Closed -$15K 2650
2019
Q4
$15K Hold
2,045
﹤0.01% 1820
2019
Q3
$17K Hold
2,045
﹤0.01% 1696
2019
Q2
$19K Hold
2,045
﹤0.01% 1666
2019
Q1
$17K Hold
2,045
﹤0.01% 1655
2018
Q4
$13K Hold
2,045
﹤0.01% 1708
2018
Q3
$19K Hold
2,045
﹤0.01% 1608
2018
Q2
$14K Hold
2,045
﹤0.01% 1594
2018
Q1
$14K Hold
2,045
﹤0.01% 1541
2017
Q4
$17K Hold
2,045
﹤0.01% 1461
2017
Q3
$23K Sell
2,045
-75
-4% -$738 ﹤0.01% 1276
2017
Q2
$24K Hold
2,120
﹤0.01% 1214
2017
Q1
$21K Buy
+2,120
New +$21.4K ﹤0.01% 1225
2016
Q4
Sell
-75
Closed -$1K 2098
2016
Q3
$1K Buy
+75
New +$940 ﹤0.01% 1960

Other funds holding XONE

Geneos Wealth Management's XONE Position: Q1 2020 in Review

Geneos Wealth Management sold out of The ExOne Company (XONE) in Q1 2020, closing a stake of 2,045 shares — an estimated $15K sold.

Geneos Wealth Management first reported a position in XONE in Q3 2016 and held it in 13 quarters. The position peaked at $24K in Q2 2017. 50 funds tracked by Wall St. Rank hold XONE as of Q1 2020.

  • Geneos Wealth Management reported no remaining The ExOne Company position as of Q1 2020 after selling out during the quarter.
  • Geneos Wealth Management sold 2,045 The ExOne Company shares in Q1 2020, an estimated $15K.
  • Geneos Wealth Management first reported a position in The ExOne Company in Q3 2016 and held it in 13 quarters.
  • Geneos Wealth Management's The ExOne Company position peaked at $24K in Q2 2017.
  • 50 funds tracked by Wall St. Rank held The ExOne Company as of Q1 2020.

Based on Geneos Wealth Management's 13F filing for Q1 2020, filed 7 Sep 2021.